Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 42,000 shares at $20.00 ($843K) on 2022-11-10, disclosed to the SEC on 2022-11-10.
Open-market sale of $843k RLAY by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.18 | 14,000 | $283K | 33.5% |
| 2 | $20.00 | 9,825 | $197K | 23.3% |
| 3 | $20.00 | 18,175 | $364K | 43.1% |
| Total | $20.06 avg | 42,000 | $843K | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $980K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |